Results 201 to 210 of about 88,293 (250)

Endocytosis‐independent cytosolic entry of messenger RNA via fluorous bilayer zippering attenuating Toll‐like receptor signaling and enables ischemic tissue salvage

Smart Molecules, EarlyView.
The present study establishes a paradigm shift in synthetic mRNA delivery through the convergence of three orthogonal chemistries—perfluoro‐acylation, bio‐orthogonal click cross‐linking, and disulfide reduction—within a single, modular polymer architecture. Abstract A fundamental constraint of conventional messenger RNA (mRNA) delivery systems is their
Yue Wang, Haitao Xie, Guoqing Xiang, Yanhua Li, Changgui Tong, Hongyan Cui, Qixian Chen, Haidong Li, Yan Zhao   +8 more
wiley   +1 more source

Comparative Quality Assessment of Artificial Intelligence in Patient Education on Platelet-Rich Plasma (PRP) Therapy. [PDF]

J Pers Med
Krueckel J, Szymski D, Ahmad N, Schiffelholz D, Weber J, Buchhorn S, Buchhorn T, Fehske K, Lang S, Alt V, Hilber F.   +10 more
europepmc   +1 more source

Comparison of ultrasound-guided dry needling and platelet-rich plasma injection in the management of refractory lateral epicondyle tendinopathy. [PDF]

Clin Shoulder Elb
Terzi MM, Kıratlıoğlu Y, Bezirgan U, Armangil M.   +3 more
europepmc   +1 more source

Effects of autologous platelet-rich plasma in recurrent implantation failure: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Pan Z, Guo X, Su Q, Ye H.
europepmc   +1 more source

Platelet-rich plasma enhances post-conditioning recovery from testicular ischemia-reperfusion injury: a novel experimental approach. [PDF]

Sci Rep
Amena-Elmongy, Gannah-Samy, Samy A, Shouman Z, Megahed A, Karrouf G.   +5 more
europepmc   +1 more source

Best evidence summary for platelet-rich plasma treatment of chronic wounds. [PDF]

Regen Ther
Zhang X, Zhang X, Wang L, Zhen L, Lin M, Li Y, Gong L, Zeng H, Ruan W, Zhu M.   +9 more
europepmc   +1 more source

Platelet-rich plasma and hyaluronic acid in the treatment of acute ankle sprains: A review. [PDF]

Biomol Biomed
Chen YT, Wu WT, Lee RP, Yu TC, Chen IH, Yeh KT.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet-Rich Plasma

Physical Medicine and Rehabilitation Clinics of North America, 2016
Platelet-rich plasma (PRP) is a growing and robust therapeutic option in musculoskeletal medicine. PRP is a preparation of autologous plasma enriched with a platelet concentration above that normally contained in whole blood. The rationale for use and therapeutic potential of a high concentration of platelets is based on their capacity to supply ...
Peter I-Kung, Wu, Robert, Diaz, Joanne, Borg-Stein   +2 more
  +6 more sources

Platelet-Rich Plasma

Clinics in Sports Medicine, 2019
Platelet-rich plasma (PRP) is a promising treatment for musculoskeletal maladies and clinical data to date have shown that PRP is safe. However, evidence of its efficacy has been mixed and highly variable depending on the specific indication. Additional future high-quality large clinical trials will be critical in shaping our perspective of this ...
Adrian D K, Le, Lawrence, Enweze, Malcolm R, DeBaun, Jason L, Dragoo   +3 more
openaire   +3 more sources